Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05742347 · ClinicalTrials.gov registry record · NA
Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions
A NA study, sponsored by Medline Industries.
- Terminated
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT05742347 is a NA study that was terminated before completion, run by Medline Industries. The registered enrollment target is 47 participants.
The verdict
NCT05742347, a NA study, was terminated before completion, sponsored by Medline Industries.
- TERMINATED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of the DriGo skin protectant textile (SPT) to manage erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor associated with skin folds (henceforth together referred to as "skin fold conditions"). Participants will be patients with skin fold conditions, which will be treated with the SPT. Healthcare providers will apply the SPT to the participants' target areas. A given participant can have up to two target areas enrolled in the study. An independent licensed clinician with experience in identifying and treating skin fold conditions, will use photographs of the skin folds and other skin-on-skin contact areas (henceforth referred to as "target area\[s\]") to assess the status of erythema, maceration, denudation, and satellite lesions in the target areas when the SPT is first applied (Day 0), and on Days 1, 3, and 5, during SPT changes. The Principal Investigator (PI) or qualified designee will take photographs of the target areas and assess moisture and odor in these areas. Participants will provide their impressions of pain, itching and burning in the target area(s) on the same days as the skin fold condition photography. In addition, the study will include feedback from the Health Care Providers (HCPs) about the SPT and overall experience of the participants with the SPT.
Interventions
- DEVICE DriGo Skin Protectant Textile
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2024-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05742347
The ClinicalTrials.gov registry entry for NCT05742347 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DriGo Skin Protectant Textile is the first listed.
NCT05742347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05742347 about?
NCT05742347 is a clinical study titled "Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions". This study will evaluate the efficacy of the DriGo skin protectant textile (SPT) to manage erythema, maceration, denudation, satellite lesions, pain, itching, burning, moisture, and odor associated with skin folds (henceforth together referred to as "skin fold conditions"). Participants will be pati...
What is the current status of trial NCT05742347?
This trial is currently terminated. It is a NA study. The enrollment target is 47 participants. The study started on 2022-07-01. Estimated completion is 2024-09-26.
What interventions are being tested in trial NCT05742347?
The interventions under investigation include: DriGo Skin Protectant Textile (DEVICE).
Who is sponsoring clinical trial NCT05742347?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.